Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps

D De Luca, P Cogo, MC Kneyber, P Biban, MG Semple… - Critical Care, 2021 - Springer
Pediatric (PARDS) and neonatal (NARDS) acute respiratory distress syndrome have
different age-specific characteristics and definitions. Trials on surfactant for ARDS in children …

Cutaneous manifestations of ANCA-associated small vessels vasculitis

AV Marzano, MG Raimondo, E Berti, PL Meroni… - Clinical reviews in …, 2017 - Springer
Skin lesions are frequent manifestations of underlying systemic conditions, including
systemic autoimmune vasculitis. In particular, anti-neutrophil cytoplasmic antibodies (ANCA) …

Primary vasculitis in childhood: GPA and MPA in childhood

MP Jariwala, RM Laxer - Frontiers in Pediatrics, 2018 - frontiersin.org
Childhood onset anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis (AAV)
is a rare group of primary systemic vasculitides affecting medium and small blood vessels …

Prognostic factors and long-term outcome with ANCA-associated kidney vasculitis in childhood

M Calatroni, F Consonni, M Allinovi… - Clinical Journal of the …, 2021 - journals.lww.com
Results A total of 53 patients had microscopic polyangiitis (62%), and 32 had
granulomatosis with polyangiitis (38%). Rapidly progressive GN was the most frequent …

Granulomatosis with polyangiitis (Wegener's granulomatosis): evolving concepts in treatment

JP Lynch III, A Derhovanessian… - … in respiratory and …, 2018 - thieme-connect.com
Granulomatosis with polyangiitis (GPA), formerly termed Wegener's granulomatosis, is the
most common of the pulmonary vasculitides. GPA typically involves the upper respiratory …

Childhood GPA, EGPA, and MPA

M Jariwala, RM Laxer - Clinical Immunology, 2020 - Elsevier
Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a term used to
describe rare primary systemic vasculitides affecting small and medium-sized blood vessels …

Association between age at disease onset of anti-neutrophil cytoplasmic antibody–associated vasculitis and clinical presentation and short-term outcomes

S Monti, A Craven, C Klersy, C Montecucco… - …, 2021 - academic.oup.com
Objectives ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show
that differences in disease presentation and 6 month outcome between younger-and older …

Prevalence of autoantibodies in pediatric patients with idiopathic pulmonary hemosiderosis: a scoping review of the literature in the period 1980–2021

BK Saha, A Bonnier, P Chenna, NT Milman - Clinical Rheumatology, 2022 - Springer
Idiopathic pulmonary hemosiderosis (IPH) is a rare disease of unknown etiology. Due to the
frequent findings of autoimmune antibodies—autoantibodies, immunologic causation of the …

[PDF][PDF] Phase IIa global study evaluating rituximab for the treatment of pediatric patients with granulomatosis with polyangiitis or microscopic polyangiitis

P Brogan, RSM Yeung, G Cleary… - Arthritis & …, 2022 - Wiley Online Library
Objective To assess the safety, tolerability, pharmacokinetics, and efficacy of rituximab (RTX)
in pediatric patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis …

Translational implications of humoral and cellular immune dysfunction in granulomatosis with polyangiitis

H Singh, U Kumar, S Senapati - Cytokine, 2023 - Elsevier
Granulomatosis with polyangiitis (GPA) is a rare systemic ANCA (Anti-neutrophil cytoplasmic
antibodies) associated vasculitis (AAV). In the last couple of decades, GPA has emerged as …